Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.438, 2003-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Vijayan Neetha N Mathew Anila Balan Shabeesh Natarajan Chandrasekhar Nair Chandrashekharan M Allencherry Priya M Banerjee Moinak
Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. :
Access to resources
Recommend
Antipsychotic compliance valuable in schizophrenia
Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. :
Olanzapine: an atypical antipsychotic for schizophrenia
Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. :
Antipsychotic polypharmacy in schizophrenia in Canada
Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. :
Guidelines for depot antipsychotic treatment in schizophrenia
By Kane J.M. Aguglia E. Altamura A.C. Gutierrez J.L.A. Brunello N. Fleischhacker W.W. Gaebel W. Gerlach J. Guelfi J.-D. Kissling W. Lapierre Y.D. Lindstrom E. Mendlewicz J. Racagni G. Carulla L.S. Schooler N.R.
European Neuropsychopharmacology, Vol. 8, Iss. 1, 1998-02 ,pp. :